Haisco Pharmaceutical Group Co., Ltd. announced that it has received CNY 800 million in funding from Jinan Jiangshan Investment Partnership Enterprise (Limited Partnership), JPMorgan Chase Bank, National Association, Fullgoal Fund Management Co., Ltd.

On January 12, 2023, Haisco Pharmaceutical Group Co., Ltd. closed the transaction. The company now issued 40,000,000 shares at an issue price of CNY 20 per share for the gross proceeds of CNY790,866,217.58. The transaction included participation from Fullgoal Fund Management Co., Ltd. for 27,250,000 shares for CNY 545,000,000, Jinan Jiangshan Investment Partnership Enterprise (Limited Partnership) for 10,000,000 shares for CNY 200,000,000, JPMorgan Chase Bank, National Association for 1,500,000 shares for CNY 30,000,000.00, Fei Zhanbo for 1,200,000 shares for CNY 24,000,000, Jiaxing Juli Zhenxin No.

1 Equity Investment Partnership Enterprise (Limited Partnership) for 50,000 shares for CNY 1,000,000. The company has also completed the registration procedures for the private placement in China Securities Depository and Clearing Co., Ltd. Shenzhen Branch.